1 |
JAK-STAT signalling pathway |
1 |
EGFR tyrosine kinase inhibitor resistance |
1 |
Cytokine-cytokine receptor interaction |
1 |
Viral protein interaction with cytokine and cytokine receptor |
1 |
Th17 cell differentiation |
2 |
Complement and coagulation cascades |
2 |
Fluid shear stress and atherosclerosis |
2 |
Prostate cancer |
2 |
Hematopoietic cell lineage |
2 |
NF-kappa B signalling pathway |
3 |
IL-17 signalling pathway |
3 |
Viral protein interaction with cytokine and cytokine receptor |
3 |
Chemokine signalling pathway |
3 |
Rheumatoid arthritis |
3 |
TNF signalling pathway |
4 |
Measles |
4 |
RIG-I-like receptor signalling pathway |
4 |
Influenza A |
4 |
NOD-like receptor signalling pathway |
4 |
Epstein-Barr virus infection |
5 |
Gap junction |
5 |
Phagosome |
5 |
Pathogenic Escherichia coli infection |
5 |
Huntington disease |
5 |
Alzheimer disease |
6 |
NF-kappa B signalling pathway |
6 |
C-type lectin receptor signalling pathway |
6 |
Osteoclast differentiation |
6 |
Apoptosis |
6 |
Epstein-Barr virus infection |
7 |
Focal adhesion |
7 |
PI3K-Akt signalling pathway |
7 |
ECM-receptor interaction |
7 |
Human papillomavirus infection |
7 |
Fluid shear stress and atherosclerosis |
8 |
TNF signalling pathway |
8 |
IL-17 signalling pathway |
8 |
NF-kappa B signalling pathway |
8 |
Cytokine-cytokine receptor interaction |
8 |
Transcriptional misregulation in cancer |
9 |
C-type lectin receptor signalling pathway |
9 |
Kaposi sarcoma-associated herpesvirus infection |
Supplementary Table 4. Continued. |
Community |
Term |
9 |
Leishmaniasis |
9 |
Osteoclast differentiation |
9 |
Necroptosis |
10 |
TGF-beta signalling pathway |
10 |
Signalling pathways regulating pluripotency of stem cells |
10 |
Staphylococcus aureus infection |
10 |
Cytokine-cytokine receptor interaction |
10 |
Tuberculosis |